PMC10329271_01
Electrocardiogram. Electrocardiogram showed low T wave, no ST-elevation or depression, and no dynamic development.
j_biol-2022-0629-fig001.jpg
PMC10329271_01_j_biol-2022-0629-fig001.jpg
j_biol-2022-0629_fig_001
We were also provided with an electrocardiogram (Figure 1) and a transesophageal echocardiogram (TEE; Figure 2a, b).
TEE. The picture shows the prosthetic aortic valve incompetence. Multiple vegetations are present in the valve frame ascending aortic wall, the largest vegetation is 28 mm x 11 mm with an obvious range of motion. There is an obvious dilation of the ascending aorta whose internal diameter is approximately 64 mm, accompanied by a thickening of the wall whose thickness is approximately 6.6 mm. There is mild regurgitation of the mitral and tricuspid valves. (a) TEE-long axis of the aorta, (b) TEE-short axis of the aorta.
j_biol-2022-0629-fig002.jpg
PMC10329271_01_j_biol-2022-0629-fig002.jpg
j_biol-2022-0629_fig_002
We were also provided with an electrocardiogram (Figure 1) and a transesophageal echocardiogram (TEE; Figure 2a, b).
The result of ultra-multiplex PCR using blood.
j_biol-2022-0629-fig003.jpg
PMC10329271_01_j_biol-2022-0629-fig003.jpg
j_biol-2022-0629_fig_003
The multiplex PCR results received on February 25 were as follows (Figure 3): Aspergillus flavus <1 x 102/L, Aspergillus oryzae <1 x 102/L, cytomegalovirus 2 x 102/L, G test 343.84 pg/mL, and GM 0.83.
The results of ptNGS. (a) 185,992 is the total series of measurements. After eliminating the number of short sequences with low quality, unmatched sequences and matched sequences with low quality, the remaining number of valid sequences is 91,975, (b) In this 91,975, the number of effective sequences filtered was 91,492, the number of Aflatus sequences was 87, the number of Aspergillus sequences was 25, and the number of human herpesvirus type 5 sequences was 371.
j_biol-2022-0629-fig004.jpg
PMC10329271_01_j_biol-2022-0629-fig004.jpg
j_biol-2022-0629_fig_004
Table 2 and Figure 4a, b. The primer sequences are as shown in Table 3.